1,215.35
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NFLX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1,219.03
Aprire:
$1214.75
Volume 24 ore:
2.36M
Relative Volume:
0.75
Capitalizzazione di mercato:
$516.43B
Reddito:
$41.46B
Utile/perdita netta:
$10.25B
Rapporto P/E:
51.79
EPS:
23.466
Flusso di cassa netto:
$8.50B
1 W Prestazione:
+2.04%
1M Prestazione:
+2.26%
6M Prestazione:
+30.50%
1 anno Prestazione:
+70.46%
Netflix Inc Stock (NFLX) Company Profile
Nome
Netflix Inc
Settore
Industria
Telefono
408-540-3700
Indirizzo
121 ALBRIGHT WAY, LOS GATOS
Confronta NFLX con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
NFLX
Netflix Inc
|
1,215.35 | 518.00B | 41.46B | 10.25B | 8.50B | 23.47 |
![]()
DIS
Walt Disney Co
|
111.17 | 198.26B | 94.13B | 12.55B | 11.55B | 6.3783 |
![]()
WBD
Warner Bros Discovery Inc
|
17.98 | 44.02B | 38.41B | 640.00M | 4.07B | 0.302 |
![]()
LYV
Live Nation Entertainment Inc
|
152.83 | 35.69B | 23.72B | 775.11M | 1.08B | 2.3024 |
![]()
FWONK
Liberty Media Corp
|
103.72 | 26.01B | 3.87B | 288.00M | 693.00M | -9.2097 |
Netflix Inc Stock (NFLX) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-10-07 | Aggiornamento | Seaport Research Partners | Neutral → Buy |
2025-09-17 | Aggiornamento | Loop Capital | Hold → Buy |
2025-07-10 | Reiterato | KeyBanc Capital Markets | Overweight |
2025-07-07 | Downgrade | Seaport Research Partners | Buy → Neutral |
2025-07-02 | Reiterato | Canaccord Genuity | Buy |
2025-07-02 | Reiterato | Goldman | Neutral |
2025-06-20 | Reiterato | Pivotal Research Group | Buy |
2025-06-12 | Reiterato | Oppenheimer | Outperform |
2025-06-03 | Reiterato | Jefferies | Buy |
2025-05-30 | Reiterato | BofA Securities | Buy |
2025-05-19 | Downgrade | JP Morgan | Overweight → Neutral |
2025-04-21 | Reiterato | BMO Capital Markets | Outperform |
2025-04-21 | Reiterato | Barclays | Equal Weight |
2025-04-21 | Reiterato | Canaccord Genuity | Buy |
2025-04-21 | Reiterato | Guggenheim | Buy |
2025-04-21 | Reiterato | JP Morgan | Overweight |
2025-04-21 | Reiterato | KeyBanc Capital Markets | Overweight |
2025-04-21 | Reiterato | MoffettNathanson | Buy |
2025-04-21 | Reiterato | Morgan Stanley | Overweight |
2025-04-21 | Reiterato | Oppenheimer | Outperform |
2025-04-21 | Reiterato | Piper Sandler | Overweight |
2025-04-21 | Reiterato | Pivotal Research Group | Buy |
2025-04-21 | Reiterato | Wells Fargo | Overweight |
2025-04-17 | Ripresa | Piper Sandler | Overweight |
2025-03-27 | Iniziato | FBN Securities | Outperform |
2025-03-17 | Aggiornamento | MoffettNathanson | Neutral → Buy |
2025-01-24 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
2025-01-23 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
2025-01-22 | Aggiornamento | Barclays | Underweight → Equal Weight |
2025-01-22 | Aggiornamento | Canaccord Genuity | Hold → Buy |
2025-01-22 | Reiterato | Oppenheimer | Outperform |
2025-01-22 | Reiterato | Pivotal Research Group | Buy |
2025-01-22 | Aggiornamento | Rosenblatt | Neutral → Buy |
2025-01-22 | Aggiornamento | The Benchmark Company | Sell → Hold |
2025-01-16 | Aggiornamento | Seaport Research Partners | Neutral → Buy |
2025-01-15 | Reiterato | BMO Capital Markets | Outperform |
2025-01-15 | Reiterato | Oppenheimer | Outperform |
2025-01-08 | Reiterato | Goldman | Neutral |
2025-01-06 | Reiterato | Argus | Buy |
2025-01-03 | Reiterato | The Benchmark Company | Sell |
2024-12-19 | Reiterato | UBS | Buy |
2024-12-16 | Downgrade | Loop Capital | Buy → Hold |
2024-12-16 | Reiterato | Oppenheimer | Outperform |
2024-12-11 | Reiterato | JP Morgan | Overweight |
2024-11-20 | Reiterato | Pivotal Research Group | Buy |
2024-10-18 | Reiterato | Needham | Buy |
2024-10-18 | Reiterato | Oppenheimer | Outperform |
2024-10-18 | Reiterato | Pivotal Research Group | Buy |
2024-10-16 | Reiterato | Loop Capital | Buy |
2024-10-11 | Reiterato | Guggenheim | Buy |
2024-10-10 | Reiterato | Morgan Stanley | Overweight |
2024-10-10 | Reiterato | Oppenheimer | Outperform |
2024-10-07 | Downgrade | Barclays | Equal Weight → Underweight |
2024-10-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
2024-10-01 | Reiterato | KeyBanc Capital Markets | Overweight |
2024-09-05 | Iniziato | China Renaissance | Hold |
2024-08-30 | Reiterato | Pivotal Research Group | Buy |
2024-07-17 | Reiterato | Guggenheim | Buy |
2024-07-16 | Reiterato | The Benchmark Company | Sell |
2024-07-15 | Reiterato | BofA Securities | Buy |
2024-07-12 | Reiterato | JP Morgan | Overweight |
2024-07-10 | Reiterato | KeyBanc Capital Markets | Overweight |
2024-07-09 | Reiterato | TD Cowen | Buy |
2024-07-02 | Reiterato | Argus | Buy |
2024-05-28 | Reiterato | Evercore ISI | Outperform |
2024-04-19 | Downgrade | Canaccord Genuity | Buy → Hold |
2024-04-19 | Aggiornamento | Needham | Hold → Buy |
2024-04-19 | Reiterato | Pivotal Research Group | Buy |
2024-04-15 | Reiterato | Deutsche Bank | Hold |
2024-04-12 | Reiterato | Morgan Stanley | Overweight |
2024-04-12 | Reiterato | Piper Sandler | Neutral |
2024-04-05 | Reiterato | Pivotal Research Group | Buy |
2024-03-25 | Reiterato | Citigroup | Neutral |
2024-03-12 | Reiterato | Jefferies | Buy |
2024-03-11 | Reiterato | Oppenheimer | Outperform |
2024-01-30 | Downgrade | Seaport Research Partners | Buy → Neutral |
2024-01-25 | Aggiornamento | DZ Bank | Hold → Buy |
2024-01-24 | Reiterato | BMO Capital Markets | Outperform |
2024-01-24 | Reiterato | BofA Securities | Buy |
2024-01-24 | Reiterato | Canaccord Genuity | Buy |
2024-01-24 | Reiterato | Evercore ISI | Outperform |
2024-01-24 | Reiterato | Goldman | Neutral |
2024-01-24 | Reiterato | Guggenheim | Buy |
2024-01-24 | Reiterato | JP Morgan | Overweight |
2024-01-24 | Reiterato | KeyBanc Capital Markets | Overweight |
2024-01-24 | Aggiornamento | Macquarie | Neutral → Outperform |
2024-01-24 | Reiterato | Morgan Stanley | Overweight |
2024-01-24 | Reiterato | Oppenheimer | Outperform |
2024-01-24 | Reiterato | Piper Sandler | Neutral |
2024-01-24 | Reiterato | Pivotal Research Group | Buy |
2024-01-24 | Reiterato | Redburn Atlantic | Buy |
2024-01-24 | Reiterato | Robert W. Baird | Outperform |
2024-01-24 | Reiterato | TD Cowen | Outperform |
2024-01-24 | Reiterato | UBS | Buy |
2024-01-24 | Reiterato | Wells Fargo | Overweight |
2023-09-18 | Reiterato | Evercore ISI | Outperform |
2023-08-25 | Aggiornamento | Loop Capital | Hold → Buy |
2023-07-24 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
2023-07-17 | Reiterato | Deutsche Bank | Buy |
2023-07-13 | Reiterato | JP Morgan | Overweight |
2023-07-12 | Reiterato | UBS | Buy |
2023-07-05 | Aggiornamento | Goldman | Sell → Neutral |
2023-06-29 | Reiterato | Citigroup | Buy |
2023-06-28 | Reiterato | Oppenheimer | Outperform |
2023-06-13 | Reiterato | BofA Securities | Buy |
2023-06-13 | Reiterato | Guggenheim | Buy |
2023-04-19 | Reiterato | Deutsche Bank | Buy |
2023-04-19 | Reiterato | JP Morgan | Overweight |
2023-04-19 | Reiterato | Jefferies | Buy |
2023-04-19 | Reiterato | Piper Sandler | Neutral |
2023-04-19 | Reiterato | Pivotal Research Group | Buy |
2023-04-19 | Reiterato | Rosenblatt | Neutral |
2023-04-19 | Aggiornamento | UBS | Neutral → Buy |
2023-04-11 | Ripresa | Robert W. Baird | Neutral |
2023-01-23 | Reiterato | Argus | Buy |
2023-01-20 | Reiterato | Canaccord Genuity | Buy |
2023-01-20 | Reiterato | Deutsche Bank | Buy |
2023-01-20 | Reiterato | Evercore ISI | Outperform |
2023-01-20 | Reiterato | Goldman | Sell |
2023-01-20 | Reiterato | Guggenheim | Buy |
2023-01-20 | Reiterato | Jefferies | Buy |
2023-01-20 | Reiterato | MoffettNathanson | Market Perform |
2023-01-20 | Reiterato | Oppenheimer | Outperform |
2023-01-20 | Reiterato | Piper Sandler | Neutral |
2023-01-20 | Reiterato | Pivotal Research Group | Buy |
2023-01-20 | Reiterato | Robert W. Baird | Neutral |
2023-01-20 | Reiterato | The Benchmark Company | Sell |
2023-01-20 | Reiterato | Wedbush | Outperform |
2023-01-20 | Reiterato | Wolfe Research | Outperform |
2023-01-12 | Aggiornamento | Jefferies | Hold → Buy |
2023-01-04 | Iniziato | New Street | Neutral |
2022-12-29 | Aggiornamento | CFRA | Sell → Buy |
2022-12-14 | Reiterato | Jefferies | Hold |
2022-12-09 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
2022-06-14 | Downgrade | The Benchmark Company | Hold → Sell |
2022-06-10 | Downgrade | Goldman | Neutral → Sell |
2022-05-16 | Aggiornamento | Wedbush | Neutral → Outperform |
2022-04-21 | Downgrade | DZ Bank | Buy → Hold |
2022-04-21 | Downgrade | Edward Jones | Buy → Hold |
2022-04-20 | Downgrade | Atlantic Equities | Overweight → Neutral |
2022-04-20 | Downgrade | BofA Securities | Buy → Underperform |
2022-04-20 | Downgrade | JP Morgan | Overweight → Neutral |
2022-04-20 | Aggiornamento | Needham | Underperform → Hold |
2022-04-20 | Downgrade | Oppenheimer | Outperform → Perform |
2022-04-20 | Downgrade | Piper Sandler | Overweight → Neutral |
2022-04-20 | Downgrade | Pivotal Research Group | Buy → Sell |
2022-04-20 | Downgrade | Stifel | Buy → Hold |
2022-04-20 | Downgrade | UBS | Buy → Neutral |
2022-04-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
2022-04-19 | Iniziato | Rosenblatt | Neutral |
2022-03-09 | Aggiornamento | Wedbush | Underperform → Neutral |
2022-01-31 | Aggiornamento | Citigroup | Neutral → Buy |
2022-01-31 | Aggiornamento | Edward Jones | Hold → Buy |
2022-01-24 | Downgrade | Jefferies | Buy → Hold |
2022-01-21 | Reiterato | BMO Capital Markets | Outperform |
2022-01-21 | Reiterato | BofA Securities | Buy |
2022-01-21 | Reiterato | Canaccord Genuity | Buy |
2022-01-21 | Reiterato | Cowen | Outperform |
2022-01-21 | Reiterato | Deutsche Bank | Hold |
2022-01-21 | Reiterato | Goldman | Neutral |
2022-01-21 | Reiterato | Guggenheim | Buy |
2022-01-21 | Reiterato | JP Morgan | Overweight |
2022-01-21 | Reiterato | MoffettNathanson | Neutral |
2022-01-21 | Downgrade | Monness Crespi & Hardt | Buy → Neutral |
2022-01-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2022-01-21 | Reiterato | Oppenheimer | Outperform |
2022-01-21 | Reiterato | Piper Sandler | Overweight |
2022-01-21 | Reiterato | Pivotal Research Group | Buy |
2022-01-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
2022-01-21 | Reiterato | Stifel | Buy |
2022-01-21 | Aggiornamento | The Benchmark Company | Sell → Hold |
2022-01-21 | Downgrade | Truist | Buy → Hold |
2022-01-21 | Reiterato | UBS | Buy |
2022-01-21 | Reiterato | Wolfe Research | Outperform |
2021-12-15 | Reiterato | The Benchmark Company | Sell |
2021-10-20 | Downgrade | Deutsche Bank | Buy → Hold |
2021-10-20 | Reiterato | Monness Crespi & Hardt | Buy |
2021-09-29 | Reiterato | The Benchmark Company | Sell |
2021-09-13 | Iniziato | Goldman | Neutral |
2021-09-08 | Reiterato | JP Morgan | Overweight |
2021-09-07 | Reiterato | Atlantic Equities | Overweight |
2021-07-21 | Reiterato | Credit Suisse | Outperform |
2021-07-21 | Reiterato | Deutsche Bank | Buy |
2021-07-21 | Reiterato | JP Morgan | Overweight |
2021-07-21 | Reiterato | KeyBanc Capital Markets | Overweight |
2021-07-21 | Reiterato | Stifel | Buy |
2021-06-25 | Aggiornamento | Credit Suisse | Neutral → Outperform |
2021-06-25 | Iniziato | Edward Jones | Hold |
2021-05-19 | Ripresa | Jefferies | Buy |
2021-04-21 | Ripresa | Oppenheimer | Outperform |
2021-04-21 | Reiterato | Pivotal Research Group | Buy |
2021-04-21 | Aggiornamento | Stifel | Hold → Buy |
2021-04-06 | Ripresa | Evercore ISI | Outperform |
2021-04-01 | Iniziato | Piper Sandler | Overweight |
2021-03-25 | Reiterato | The Benchmark Company | Sell |
2021-03-23 | Aggiornamento | Argus | Hold → Buy |
2021-01-21 | Aggiornamento | DZ Bank | Hold → Buy |
2021-01-20 | Reiterato | Monness Crespi & Hardt | Buy |
2021-01-20 | Reiterato | Pivotal Research Group | Buy |
2021-01-20 | Reiterato | The Benchmark Company | Sell |
2021-01-20 | Aggiornamento | UBS | Neutral → Buy |
2021-01-20 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
2020-10-21 | Reiterato | BMO Capital Markets | Outperform |
2020-10-21 | Reiterato | Bernstein | Outperform |
2020-10-21 | Reiterato | Jefferies | Buy |
2020-10-21 | Reiterato | Morgan Stanley | Overweight |
2020-10-21 | Reiterato | Oppenheimer | Outperform |
2020-10-21 | Reiterato | Piper Sandler | Overweight |
2020-10-21 | Reiterato | Pivotal Research Group | Buy |
2020-10-21 | Reiterato | RBC Capital Mkts | Outperform |
2020-10-21 | Reiterato | The Benchmark Company | Sell |
2020-10-21 | Reiterato | Wedbush | Underperform |
2020-10-21 | Reiterato | Wells Fargo | Equal Weight |
2020-10-16 | Reiterato | Morgan Stanley | Overweight |
2020-10-15 | Reiterato | Canaccord Genuity | Buy |
2020-10-14 | Reiterato | Goldman | Buy |
2020-10-07 | Reiterato | Pivotal Research Group | Buy |
2020-09-28 | Reiterato | The Benchmark Company | Sell |
2020-09-15 | Iniziato | KeyBanc Capital Markets | Overweight |
2020-09-09 | Ripresa | Raymond James | Mkt Perform |
2020-09-04 | Reiterato | The Benchmark Company | Sell |
2020-07-29 | Reiterato | Loop Capital | Buy |
Mostra tutto
Netflix Inc Borsa (NFLX) Ultime notizie
Netflix, TF1 Team on ‘The Countess of Monte Cristo’ With Hpi’ Star Audrey Fleurot - IMDb
Minnetonka footwear collaborates with Netflix’s ‘Stranger Things’ for new style - Star Tribune
Netflix Sets Premiere Date For Eddie Murphy Doc ‘Being Eddie’ - IMDb
Netflix vs. Amazon: Which Streaming Giant Has Better Upside Potential? - The Globe and Mail
Nasdaq 2026 Breakout? Netflix, Meta and AI Stocks Poised for Stock-Split Frenzy! - ts2.tech
Hixon Zuercher Sells $3.1 Million in Netflix Stock Ahead of Earnings After 70% Surge - The Motley Fool
Netflix Stock Up 70% In 12 MonthsWhat Drove It? - Forbes
Netflix’s Beauty In the Beast Casts Lomon in a Role That Got Taylor Lautner His Fame - IMDb
Netflix, Inc. $NFLX Shares Acquired by Sagespring Wealth Partners LLC - MarketBeat
‘We Remain Favorable on NFLX’: Jefferies Keeps Faith in Netflix Stock as Q3 Earnings Approach - TipRanks
TD Asset Management Inc Has $736.90 Million Stock Position in Netflix, Inc. $NFLX - MarketBeat
Morningstar Investment Management LLC Buys 2,168 Shares of Netflix, Inc. $NFLX - MarketBeat
Netflix, Inc. $NFLX Shares Purchased by RFG Advisory LLC - MarketBeat
Axxcess Wealth Management LLC Purchases 581 Shares of Netflix, Inc. $NFLX - MarketBeat
Typhoon Family: Kim Min-ha, Lee Joon-ho in ’90s financial crisis K-drama - South China Morning Post
Netflix stock price target maintained at $1,500 by Jefferies - Investing.com
Netflix, Inc. $NFLX Shares Purchased by Vest Financial LLC - MarketBeat
NETFLIX COM INC : Jefferies reiterates its Buy rating - MarketScreener
Millie Bobby Brown and Rachel Brosnahan Team Up for New Supernatural Netflix Series - IMDb
Millie Bobby Brown and Rachel Brosnahan Join Forces for New Supernatural Netflix Series “Prism” - IMDb
Fake company names has become a Tim Robinson specialty / Netflix's Prism is Millie Bobby Brown's next series / How late-night could stay relevant - TV Tattle
‘The Twits’ Review: Netflix’s Animated Roald Dahl Adaptation Goes From Grossly Generic to Surprisingly Political - IMDb
Netflix earnings preview: focus shifts from subscribers to monetisation - ig.com
Netflix Stock (NFLX) Stays on Comeback Trail Ahead of Q3 Results - TipRanks
Yujin, Ji Hyun-woo's tearful embrace boosts 'First Lady' Netflix rank - 조선일보
Millie Bobby Brown To Star In New Netflix Supernatural Series Prism - IMDb
Netflix makes a major move to win over subscribers - TheStreet
Juan Gabriel Rises to International Stardom in First Trailer for Netflix Docuseries: Watch - billboard.com
‘Prism’ – Millie Bobby Brown Starring in Supernatural Series for Netflix - IMDb
Millie Bobby Brown, Rachel Brosnahan & Agbo Developing Supernatural Series ‘Prism’ At Netflix - IMDb
Netflix Removing Original Branding From Movie and Series Tiles – Here’s Why - What's on Netflix
Netflix Q3 Earnings On Deck: Is NFLX Stock A Buy Ahead Of October 21? - Barchart.com
‘Bridgerton’ Season 4 Premiere Date Announced by Netflix: Two-Part Winter 2026 Rollout - IMDb
Netflix Earnings Preview: Focus Shifts From Subscribers To Monetisation - ig.com
Netflix’s SWOT analysis: streaming giant’s stock faces growth challenges By Investing.com - Investing.com Canada
Netflix’s SWOT analysis: streaming giant’s stock faces growth challenges - Investing.com
Netflix, Inc. (NFLX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
How Will Netflix Stock Respond To Its Upcoming Earnings? - Forbes
Netflix, BBC and Others Sent Legal Letter Over Israel Film Boycott Signed by Joaquin Phoenix, Olivia Colman: ‘Highly Likely to Be a Litigation Risk’ (Exclusive) - IMDb
Victoria Beckham gives glimpse into beauty empire in new Netflix documentary - Cosmetics Business
Netflix, Inc. $NFLX Shares Acquired by NorthRock Partners LLC - MarketBeat
Netflix marks 10 years in Italy with €1.1bn local investment - Broadband TV News
Atria Wealth Solutions Inc. Reduces Stock Position in Netflix, Inc. $NFLX - MarketBeat
Netflix, Inc. $NFLX Shares Purchased by Envestnet Portfolio Solutions Inc. - MarketBeat
Montrusco Bolton Investments Inc. Raises Stock Holdings in Netflix, Inc. $NFLX - MarketBeat
Total Clarity Wealth Management Inc. Raises Stock Holdings in Netflix, Inc. $NFLX - MarketBeat
Sequoia Financial Advisors LLC Increases Stake in Netflix, Inc. $NFLX - MarketBeat
Pegasus Asset Management Inc. Acquires New Shares in Netflix, Inc. $NFLX - MarketBeat
Cypress Capital Group Buys 1,071 Shares of Netflix, Inc. $NFLX - MarketBeat
What Makes The Diplomat Click? People Crave ‘Competency Porn’ - Bloomberg.com
Mitchell Capital Management Co. Reduces Stock Holdings in Netflix, Inc. $NFLX - MarketBeat
Netflix Inc Azioni (NFLX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):